Fares E M Ali

21PUBLICATIONS
13CO-AUTHORS
ChemotherapyBiologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 29, 2025
The Involvement of RIPK-3/Caspase-8 Inhibition and Nrf2/HO-1 Upregulation in the Protective Effect of Umbelliferone Against Chlorpyrifos-Induced Pulmonary Toxicity.

Wesam H Abdulaal, Nourelhuda A Mohammed, Ehab S Taher

|Oct 17, 2023
Perindopril Dampens Cd-induced Nephrotoxicity by Suppressing Inflammatory Burden, Ang II/Ang 1-7, and Apoptosis Signaling Pathways.

Zuhair M Mohammedsaleh, Emad H M Hassanein, Fares E M Ali

|Mar 13, 2023
Apocynin abrogates methotrexate-induced nephrotoxicity: role of TLR4/NF-κB-p65/p38-MAPK, IL-6/STAT-3, PPAR-γ, and SIRT1/FOXO3 signaling pathways.

Emad H M Hassanein, Ahmed M Sayed, Omnia A M Abd El-Ghafar

|Jan 16, 2023
Exploring the cardioprotective effects of canagliflozin against cisplatin-induced cardiotoxicity: Role of iNOS/NF-κB, Nrf2, and Bax/cytochrome C/Bcl-2 signals.

Fares E M Ali, Emad H M Hassanein, Omnia A M Abd El-Ghafar

Pageof 4